Ask AI
ProCE Banner Activity

Principais estudos sobre HIV que influenciam a minha prática após a CROI 2023

Slideset

Baixe os slides para revisar os resumos dos principais estudos sobre HIV da CROI 2023, incluindo resultados de estudos sobre estratégias de prevenção, terapias de ação prolongada, eventos adversos da TARV, terapias de segunda linha e coinfecção.

Released: March 23, 2023

Share

Supporters

Supported by educational grants from

Gilead Sciences, Inc.

Janssen Therapeutics, Division of Janssen Products, LP

Merck & Co., Inc.

ViiV Healthcare

Faculty Disclosure

Primary Author

Eric S. Daar, MD

Chief, Division of HIV Medicine
Harbor – UCLA Medical Center
Professor of Medicine
David Geffen School of Medicine at UCLA
Torrance, California

Eric S. Daar, MD: consultor/conselheiro/palestrante: Gilead, GSK, Merck, Theratechnologies, ViiV; pesquisador: Gilead Sciences, GSK, ViiV.

Joseph J. Eron, MD

Herman and Louise Smith Distinguished Professor of Medicine
University of North Carolina at Chapel Hill School of Medicine
Chapel Hill, North Carolina

Joseph J. Eron Jr., MD: consultor/conselheiro/palestrante: Gilead Sciences, GlaxoSmithKline, Janssen, Merck, ViiV; pesquisador: Gilead Sciences, ViiV.

Monica Gandhi, MD, MPH

Professor of Medicine, UCSF
Associate Chief, Division of HIV, Infectious Diseases, and Global Medicine 
Director, UCSF Center for AIDS Research (CFAR)
San Francisco, California

Monica Gandhi, MD, MPH, não tem relações financeiras relevantes a divulgar.

Princy N. Kumar, MD, FIDSA, MACP

Professor of Medicine and Microbiology
Chief, Division of Infectious Diseases and Tropical Medicine
Vice Dean for Student Affairs
Georgetown University School of Medicine
Washington, DC

Princy N. Kumar, MD, FIDSA, MACP: consultora/conselheira/palestrante: Johnson & Johnson, Thera, ViiV; pesquisadora: Merck; ações e opções de ações individuais negociadas publicamente: Gilead, Pfizer.

Chloe Orkin, MBChB, FRCP, MD

Professor of Infection and Inequities
Dean for Healthcare Transformation
Faculty of Medicine and Dentistry
Queen Mary University of London
Honorary Consultant Physician, Barts Health NHS Trust
London, United Kingdom

Chloe Orkin, MBChB, FRCP, MD: consultant/advisor/speaker: Gilead, GSK, MSD, ViiV; researcher: AstraZeneca, Gilead, GSK, MSD, ViiV.

Babafemi Taiwo, MBBS

Gene Stollerman Professor of Medicine
Chief, Division of Infectious Diseases
Northwestern University
Chicago, Illinois

Babafemi Taiwo, MBBS: consultor: Gilead, GlaxoSmithKline, Johnson & Johnson, ViiV.